4
Changes in Ownership
Cabaletta Bio, Inc. Filed Acc 0000950170-23-054234
See Remarks sold 11,000 shares at an average $13.36 ($146,921)
- See Remarks acquired 11,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Binder Gwendolyn See Remarks | 2023-10-19 | Option exercise | +11,000 | $1.01 | $11,110 | 31,000 | D: show line 1 in the form |
| Binder Gwendolyn See Remarks | 2023-10-19 | Sale | −10,592 | $13.32 | $141,096 | 20,408 | D: show line 2 in the form |
| Binder Gwendolyn See Remarks | 2023-10-19 | Sale | −408 | $14.28 | $5,825 | 20,000 | D: show line 3 in the form |
| Open-market sales · 11,000 sh · avg $13.36 · $146,921 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Binder Gwendolyn See Remarks | 2023-10-19 | Option exercise · Stock Option (Right to Buy) | −11,000 | 133,756 | D: show line 4 in the form |
Loading xslF345X05/ownership.xml…